Insider trades
William D. Waddill, Director of Protagonist Therapeutics PTGX, has filed 0 purchases and 21 sales on the open market. Over the past 12 months that comes to a net sale of $6.1M. The latest trade was on 06/23.
William D. Waddill
Director
- First filing
- 23/01/11
- Trades
- 58 trades
- Buys / sales
- 0 / 21
- 12-month net buying
- −$6.1M
- Last trade
- 06/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/23 | 06/25 | 9,000 sh | $117.94 | $1,061,460 | −53.5% | |
| Open-market sale10b5-1 plan | 06/10 | 06/11 | 9,000 sh | $107.68 | $969,120 | −53.5% | |
| Open-market sale10b5-1 plan | 05/29 | 06/01 | 9,000 sh | $99.64 | $896,760 | −53.5% | |
| Open-market sale | 02/06 | 02/06 | 20,000 sh | $83.68 | $1,673,600 | −71.9% | |
ARWR | Open-market sale10b5-1 plan | 25/12/19 | 25/12/23 | 8,367 sh3 trades | $67.65avg. | $566,038.07 | −12.9% |
PTGX | Open-market sale10b5-1 plan | 25/10/10 | 25/10/14 | 12,000 sh2 trades | $81.62avg. | $979,480 | −70.1% |
| Open-market sale10b5-1 plan | 25/09/22 | 25/09/24 | 4,000 sh | $64.25 | $257,000 | −43.8% | |
| Open-market sale10b5-1 plan | 25/08/27 | 25/08/29 | 4,000 sh | $59.25 | $237,000 | −30.5% | |
| Open-market sale10b5-1 plan | 25/03/17 | 25/03/19 | 4,000 sh | $54.25 | $217,000 | −23.4% | |
ARWR | Open-market sale10b5-1 plan | 24/12/16–24/12/17 | 24/12/18 | 7,495 sh2 trades | $21.97avg. | $164,665.08 | −15.7% |
| Open-market sale10b5-1 plan | 24/09/10 | 24/09/12 | 8,000 sh | $45.00 | $360,000 | −40.0% | |
| Open-market sale10b5-1 plan | 24/07/24 | 24/07/26 | 8,000 sh | $40.00 | $320,000 | −40.0% | |
| Open-market sale10b5-1 plan | 24/06/07 | 24/06/11 | 8,000 sh | $35.00 | $280,000 | −40.0% | |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/01 | 12,975 sh | $31.34 | $406,636.5 | −52.0% | |
ARWR | Open-market sale10b5-1 plan | 24/01/11 | 24/01/16 | 3,934 sh2 trades | $38.07avg. | $149,758.54 | −7.6% |
| Open-market sale | 23/01/09 | 23/01/11 | 3,200 sh | $30.00 | $96,000 | −10.0% |
